December 8, 2006

Welcome

8:00 AM

Roberto Machado, MD
National Heart, Lung, and Blood Institute, NIH, DHHS

Session 3
Future Therapy of Pulmonary Arterial Hypertension:
Reversing Advanced Disease with Anti-proliferative Agents

Session
Chairs:

Hossein A. Ghofrani, MD, University Hospital Giessen, Germany

Vallerie V. McLaughlin, MD, University of Michigan, Ann Arbor

8:05 AM	The Future Role of PDGF Inhibition in Treatment of Pulmonary Hypertension Ralph Schermuly, PhD Justus-Liebig University of Giessen, Germany
8:30 AM	CO Gas Augustine M.K. Choi, MD University of Pittsburgh School of Medicine
8:55 AM	Therapy with Nitrite Mark T. Gladwin, MD National Heart, Lung, and Blood Institute, NIH, DHHS
9:20 AM	Future Therapies of PH: Antiproliferative Strategies Targeting Cell Cycle Regulators Manfred Boehm, MD National Heart, Lung, and Blood Institute, NIH, DHHS
9:45 AM	Future Therapies for Pulmonary Hypertension: Statins Reda Ebeid Girgis, MB, BCh The Johns Hopkins University School of Medicine
10:10 AM	Break
10:30 AM	Mitochondria, Transcription Factors and K+ Channels: New Understanding of the Mechanisms Causing Impaired Apoptosis and Excessive Cell Proliferation in Pulmonary Arterial Hypertension Stephen Archer, MD University of Alberta, Canada
10:55 AM	The Serotonin Pathway And Related Therapeutic Strategies In Pulmonary Hypertension Serge Adnot, MD, PhD Henri Mondor Hospital, France

11:20 AM

Neuropeptides in the Treatment of Pulmonary Diseases
Lutz-Henning Block, MD
Medical University of Vienna

11:45

RhoA/Rho Kinase-mediated Vasoconstriction in Rat Models of Pulmonary Hypertension
Ivan F. McMurtry, PhD
University of South Alabama School of Medicine

Poster Session II

Chair:	Roberto Machado, MD, National Heart, Lung, and Blood Institute, NIH, DHHS
12:15 PM	Award winning poster viewing and discussion;Lunch

Session 4
Future Research Opportunities: NIH Support of Competitive Research (SCCOR)

Session
Chairs:

James Kiley, PhD, National Heart, Lung, and Blood Institute, NIH, DHHS

Steven D. Nathan, MD, Inova Fairfax Hospital, Virginia

1:30 PM

NHLBI Extramural Program in Pulmonary Hypertension
James Kiley, PhD
National Heart, Lung, and Blood Institute, NIH, DHHS

1:45 PM

Unique Challenges in Scleroderma-related PAH
Paul Hassoun, MD
Johns Hopkins University School of Medicine

2:10 PM

Research Opportunities
Kurt R. Stenmark, MD
University of Colorado Health Sciences Center

Session 5
Future Strategies in the Management of Pulmonary Arterial Hypertension

Session
Chair:

Steven D. Nathan, MD, Inova Fairfax Hospital, Virginia

2:30 PM

Screening Populations at Risk for Pulmonary Arterial Hypertension and the Role of a Registry
Michael McGoon, MD
Mayo College of Medicine

2:50 PM

What Have We Learned and What Do We Need to Know About the Treatment of Pulmonary Hypertension?
Nazzareno Galiè, MD
University of Bologna, Italy

Conclusion

3:15 PM

Closing Comments
Roberto Machado, MD
National Heart, Lung, and Blood Institute, NIH, DHHS